Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Type
6.1 Neurology Devices
6.1.1 By Type of Device
6.1.1.1 Cerebrospinal Fluid Management Devices
6.1.1.1.1 Cerebral External Drainage
6.1.1.1.2 Cerebral Shunts
6.1.1.2 Interventional Neurology Devices
6.1.1.2.1 Neurothrombectomy Devices
6.1.1.2.1.1 Snare Devices
6.1.1.2.1.2Suction Aspiration Devices
6.1.1.2.1.3 Clot Retrievers
6.1.1.2.2 Cerebral Balloon Devices
6.1.1.2.2.1 Filter Devices
6.1.1.2.2.2 Balloon Occlusion Devices
6.1.1.2.2.3 Carotid Artery
6.1.1.2.3 Aneurysm Coiling & Embolization
6.1.1.2.3.1 Liquid Embolic Agents Embolic Coils
6.1.1.2.3.2 Flow Diversion Devices Liquid Embolic Agents
6.1.1.2.3.3 Embolic Coils
6.1.1.2.4 Support Devices
6.1.1.3 Neurosurgery Devices
6.1.1.3.1 Ultrasonic Aspirators Neuroendoscopes
6.1.1.3.2 Neuroendoscopes Stereotactic Systems
6.1.1.3.3 Stereotactic Systems Aneurysm Clips
6.1.1.3.4 Aneurysm Clips
6.1.1.4 Neurostimulation Devices
6.1.1.4.1 Deep Brain Stimulation Devices
6.1.1.4.2 Sacral Nerve Stimulation Devices
6.1.1.4.3 Spinal Cord Stimulation Devices
6.1.1.4.4 Vagus Nerve Stimulation Devices
6.1.1.4.5 Gastric Electric Stimulation Devices
Chapter 7 Market Segmentation by geography
7.1 Introduction
7.2 South Africa
Chapter 8 Competitive Landscape
8.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
8.2 Strategies Adopted by Top Companies
8.3 Market Share Analysis
Chapter 9 Company Profiles
9.1 Stryker Corporation
9.1.1 Introduction
9.1.2 Company overview
9.1.3 Financial Performance
9.1.4 Product Benchmarking
9.2 Johnson & Johnson
9.3 Terumo Corporation
9.4 Penumbra, Inc.
9.5 Boston Scientific Corporation
9.6 FPD
9.7 Environeering
9.8 Signostics
9.9 Ellex
9.10 BTG plc
9.11 Byer (Pty) Ltd
9.12 Better Nutrition (Pty) Ltd
9.13 Bioclones (Pty) Ltd
9.14 Bioforce SA (Pty) Ltd
9.15 Byk Madus (Pty) Ltd
Chapter 10 Market Estimates and Forecast
10.1 Market Estimation and Forecast 2018-2024(USD Billion)
10.1.1 Market Estimates and Forecast by Type 2018-2024 (USD Billion)
10.1.2 Market Estimates and Forecast by Geography 2018-2024 (USD Billion)
10.1.3 Market Estimates and Forecast by Company 2018-2024 ( USD Billion)
Chapter 11 Market Insights
11.1 Insights of Industry Experts
11.2 Investment Opportunities
11.3 Analyst Opinion
Chapter 12 Appendix
12.1 List of Tables
12.2 List of Figures
